Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.
3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. Pediatrix Medical Group's current 3-Year Share Buyback Ratio was 0.00%.
The historical rank and industry rank for Pediatrix Medical Group's 3-Year Share Buyback Ratio or its related term are showing as below:
During the past 13 years, Pediatrix Medical Group's highest 3-Year Share Buyback Ratio was 19.40%. The lowest was -33.10%. And the median was 0.50%.
FRA:PDC's 3-Year Share Buyback Ratio is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: -1.75 * Ranked among companies with meaningful 3-Year Share Buyback Ratio only.
Pediatrix Medical Group (FRA:PDC) 3-Year Share Buyback Ratio Explanation
A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.
Be Aware
Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.
Pediatrix Medical Group 3-Year Share Buyback Ratio Related Terms
FRA:PDC vs ADUS, AVAH, SGRY: 3-Year Share Buyback Ratio Comparison
For the Medical Care Facilities subindustry, Pediatrix Medical Group's 3-Year Share Buyback Ratio, along with its competitors' market caps and 3-Year Share Buyback Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pediatrix Medical Group 3-Year Share Buyback Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Pediatrix Medical Group's 3-Year Share Buyback Ratio distribution charts can be found below:
* The bar in red indicates where Pediatrix Medical Group's 3-Year Share Buyback Ratio falls into.
Pediatrix Medical Group 3-Year Share Buyback Ratio Calculation
This is the annualized percentage change in shares outstanding from three years ago to the current year. The annualized percentage change is calculated with expontential compound based on the latest four years of annual data on Shares Outstanding (EOP).
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
What does a 3-Year Share Buyback Ratio of 0.00 mean?
Pediatrix Medical Group (FRA:PDC) has a 3-Year Share Buyback Ratio of 0.00 as of Jun. 2026. The 3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. View historical data for Pediatrix Medical Group and its competitors. According to the industry distribution chart, Pediatrix Medical Group ranks #999999 out of 446 companies in the Healthcare Providers & Services industry.
Is Pediatrix Medical Group's 3-Year Share Buyback Ratio too high?
Pediatrix Medical Group's current 3-Year Share Buyback Ratio is 0.00. Based on the distribution chart, Pediatrix Medical Group ranks #999999 out of 446 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Pediatrix Medical Group has a GF Score™ of 50/100, reflecting its overall financial health beyond just this single metric.
How does Pediatrix Medical Group's 3-Year Share Buyback Ratio compare to ADUS and AVAH?
According to the Healthcare Providers & Services industry distribution chart, Pediatrix Medical Group ranks #999999 out of 446 companies for 3-Year Share Buyback Ratio. This places Pediatrix Medical Group in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Share Buyback Ratio for a Healthcare Providers & Services company?
A good 3-Year Share Buyback Ratio depends on the Healthcare Providers & Services industry context. However, 3-Year Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Share Buyback Ratio mean?
A high 3-Year Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. View historical data for Pediatrix Medical Group and its competitors. Pediatrix Medical Group's current 3-Year Share Buyback Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pediatrix Medical Group stock overvalued right now?
Pediatrix Medical Group (FRA:PDC) has a current 3-Year Share Buyback Ratio of 0.00. The stock's GF Value™ is €11.38, compared to a current price of €22.60 — trading 98.6% above its estimated fair value. The current 3-Year Share Buyback Ratio is 0.00. Pediatrix Medical Group's overall GF Score™ is 50/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Share Buyback Ratio calculated?
3-Year Share Buyback Ratio is calculated from a company's financial statements. For Pediatrix Medical Group (FRA:PDC), the current 3-Year Share Buyback Ratio is 0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pediatrix Medical Group (FRA:PDC) Overvalued in 2026?
Based on GuruFocus' analysis, Pediatrix Medical Group stock appears to be overvalued.
The current stock price of €22.60 is trading 98.6% above its estimated GF Value™ of €11.38.
Key valuation signals for FRA:PDC:
3-Year Share Buyback Ratio: 0.00
GF Value™: €11.38 vs. price of €22.60 (98.6% above fair value)
No single metric tells the full story. See the FRA:PDC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.
50GF Score
Get the complete analysis for FRA:PDC
3-Year Share Buyback Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:PDC has been successfully added to your 
